The new Rutgers REACH hub will identify innovative health-related technologies by using the expertise of the National Cancer Institute-funded Rutgers Cancer Institute, RITMS, and the New Jersey Center for Biomaterials (NJCBM). These technologies will be evaluated for commercialization feasibility, especially as they relate to providing precision therapy to tackle an unmet need created by the heterogeneity of disease development and response to treatment. Addressing such needs can provide assets tailored to patients’ therapeutic responses that ultimately improve health. To learn more about the hub.
Home / News / From NJBIZ.com: Rutgers ROI Program to integrate strengths in biomedical sciences, expertise in research commercialization
Recent Posts
- Scientists Discover Potential Blood Test for Asthma Diagnosis and Severity.
- Local News Rutgers-Camden teams up with South Jersey charter school to ease nursing shortage.
- NJACTS Community Engagement Core COVID-19 Resources
- How to Prepare for Respiratory Illness Season: Get Vaccinated.
- Vision Therapy Reverses Concussion-Related Double and Blurred Vision, NJIT-Led Study Finds.
Categories
- Community (2,360)
- Covid (992)
- CTO Events (6)
- News (2,997)
- Pilots (21)